RESMED INC News
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
see moreRESMED INC Market News
16d
ResMed Launches AirTouch F40 Full‑Face Fabric CPAP Mask in U.S., Expanding Product Line
- ResMed has introduced the AirTouch™ F40 full‑face fabric CPAP mask in the U.S., marking its latest product innovation in sleep health.
05 Oct at 19:23
ResMed Schedules Q1 FY2027 Earnings for October 29, 2026
ResMed (NYSE: RMD) has officially announced its first quarter fiscal 2027 earnings release, scheduled for October 29, 2026, setting the stage for investor expectations.
21 Sep at 19:24
ResMed Closes Sale of MatrixCare and Receives Analyst Upgrades Amid Strategic Refocus
ResMed (RMD) closed the $490M sale of its MatrixCare software unit on August 31, 2026, strengthening its focus on sleep-health and breathing-care segments. Analyst KeyBanc raised its price target to $267, reflecting confidence in the strategic shift.
07 Sep at 19:23
ResMed Shares Rise on $450M Accelerated Share Repurchase and MatrixCare Divestiture
ResMed (RMD) announced a $450 million accelerated share repurchase and completed the sale of its MatrixCare software business, pushing strategic momentum.
24 Aug at 19:24
ResMed Appoints Carol Burt as Lead Director Amid Strong Q4 Results and Shareholder Returns
ResMed names Carol Burt lead director following Ron Taylor’s retirement; latest Q4 earnings show record revenue and $1B+ returned to shareholders.